# Dexamethasone and Respiratory Function After Mastectomy

> **NCT02305173** · PHASE3 · COMPLETED · sponsor: **Instituto Mexicano del Seguro Social** · enrollment: 120 (actual)

## Conditions studied

- Respiratory; Disorder, Functional, Impaired

## Interventions

- **DRUG:** Intravenous Dexamethasone
- **DRUG:** intravenous salin water

## Key facts

- **NCT ID:** NCT02305173
- **Lead sponsor:** Instituto Mexicano del Seguro Social
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-11
- **Final completion:** 2016-11
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02305173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02305173, "Dexamethasone and Respiratory Function After Mastectomy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02305173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*